相似文献
1
Istaroxime and Beyond: New Therapeutic Strategies to Specifically Activate SERCA and Treat Heart Failure.
J Pharmacol Exp Ther. 2023 Jan;384(1):227-230. doi: 10.1124/jpet.122.001446.
2
Istaroxime, a stimulator of sarcoplasmic reticulum calcium adenosine triphosphatase isoform 2a activity, as a novel therapeutic approach to heart failure.
Am J Cardiol. 2007 Jan 22;99(2A):24A-32A. doi: 10.1016/j.amjcard.2006.09.003. Epub 2006 Sep 25.
3
Targeting SERCA2a as an innovative approach to the therapy of congestive heart failure.
Med Hypotheses. 2007;68(5):1120-5. doi: 10.1016/j.mehy.2006.08.045. Epub 2006 Nov 17.
4
Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?
Heart Fail Rev. 2009 Dec;14(4):277-87. doi: 10.1007/s10741-009-9136-z. Epub 2009 Feb 24.
5
Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition.
Br J Pharmacol. 2013 Aug;169(8):1849-61. doi: 10.1111/bph.12278.
6
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function.
J Pharmacol Exp Ther. 2023 Jan;384(1):231-244. doi: 10.1124/jpet.122.001335. Epub 2022 Sep 24.
7
Istaroxime in heart failure new hope or more hype.
J Am Coll Cardiol. 2008 Jun 10;51(23):2286-8. doi: 10.1016/j.jacc.2008.04.005.
8
Istaroxime: an investigational luso-inotropic agent for acute heart failure syndromes.
Am J Cardiol. 2007 Jan 22;99(2A):1A-3A. doi: 10.1016/j.amjcard.2006.09.001. Epub 2006 Sep 18.
9
Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure.
J Am Coll Cardiol. 2008 Jun 10;51(23):2276-85. doi: 10.1016/j.jacc.2008.03.015. Epub 2008 Apr 9.
10
Istaroxime: A Novel Therapeutic Agent for Acute Heart Failure.
Cardiol Rev. 2025;33(2):187-190. doi: 10.1097/CRD.0000000000000598. Epub 2023 Oct 9.
引用本文的文献
1
Long AKAP18 isoforms anchor ubiquitin specific proteinases and coordinate calcium reuptake at the sarcoplasmic reticulum.
J Biol Chem. 2025 May 29;301(7):110317. doi: 10.1016/j.jbc.2025.110317.
2
Current Targets and Future Directions of Positive Inotropes for Heart Failure.
Curr Med Chem. 2024;31(42):6971-6991. doi: 10.2174/0109298673262360231018193823.
3
FRET assay for live-cell high-throughput screening of the cardiac SERCA pump yields multiple classes of small-molecule allosteric modulators.
Res Sq. 2023 Feb 28:rs.3.rs-2596384. doi: 10.21203/rs.3.rs-2596384/v1.
4
Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure.
J Clin Med. 2022 Dec 18;11(24):7503. doi: 10.3390/jcm11247503.
本文引用的文献
1
Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes.
J Pharmacol Exp Ther. 2023 Jan;384(1):116-122. doi: 10.1124/jpet.121.001251. Epub 2022 Jul 25.
2
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function.
J Pharmacol Exp Ther. 2023 Jan;384(1):231-244. doi: 10.1124/jpet.122.001335. Epub 2022 Sep 24.
3
Safety and efficacy of istaroxime in patients with acute heart failure-related pre-cardiogenic shock - a multicentre, randomized, double-blind, placebo-controlled, parallel group study (SEISMiC).
Eur J Heart Fail. 2022 Oct;24(10):1967-1977. doi: 10.1002/ejhf.2629. Epub 2022 Aug 22.
4
Aberrant PLN-R14del Protein Interactions Intensify SERCA2a Inhibition, Driving Impaired Ca Handling and Arrhythmogenesis.
Int J Mol Sci. 2022 Jun 22;23(13):6947. doi: 10.3390/ijms23136947.
5
Updated ACC/AHA/HFSA 2022 guidelines on heart failure: what is new? From epidemiology to clinical management.
Eur Heart J Cardiovasc Pharmacother. 2022 Aug 11;8(5):e23-e24. doi: 10.1093/ehjcvp/pvac029.
6
Glycation of ryanodine receptor in circulating lymphocytes predicts the response to cardiac resynchronization therapy.
J Heart Lung Transplant. 2022 Apr;41(4):438-441. doi: 10.1016/j.healun.2021.12.008. Epub 2021 Dec 26.
7
Istaroxime treatment ameliorates calcium dysregulation in a zebrafish model of phospholamban R14del cardiomyopathy.
Nat Commun. 2021 Dec 9;12(1):7151. doi: 10.1038/s41467-021-27461-8.
8
Heart failure in diabetes.
Metabolism. 2021 Dec;125:154910. doi: 10.1016/j.metabol.2021.154910. Epub 2021 Oct 8.
9
Advances in the understanding of excitation-contraction coupling: the pulsing quest for drugs against heart failure and arrhythmias.
Eur Heart J Cardiovasc Pharmacother. 2021 Nov 3;7(6):e91-e93. doi: 10.1093/ehjcvp/pvab069.
10
Cellular Mechanisms Underlying the Low Cardiotoxicity of Istaroxime.
J Am Heart Assoc. 2021 Jul 20;10(14):e018833. doi: 10.1161/JAHA.120.018833. Epub 2021 Jul 3.
Zotero 插件